Entrada Therapeutics Inc (NAS:TRDA) Stock News, Headlines & Updates
Entrada Therapeutics Inc Stock News from GuruFocus
- 1
Jun 03, 2025
Entrada Therapeutics (TRDA) Welcomes New Board Member | TRDA Stock News
GuruFocus News • 6:32am
Entrada Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors
Marketwired • 6:00am
Jun 02, 2025
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 4:00pm
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | TRDA Stock News
GuruFocus News • 3:48pm
May 28, 2025
Entrada Therapeutics Receives Authorization in the European Union to Initiate ELEVATE-45-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-45 in Patients Living with Duchenne Muscula
GuruFocus News • 6:22am
Entrada Therapeutics (TRDA) Gains EU Approval for Advanced Clinical Study | TRDA Stock News
GuruFocus News • 6:20am
May 20, 2025
Entrada Therapeutics (TRDA) Receives 'Buy' Rating Reiteration by HC Wainwright | TRDA Stock News
GuruFocus News • 6:30am
May 12, 2025
Entrada Therapeutics (TRDA) Sees Price Target Adjustment Amid Clinical Progress | TRDA Stock News
GuruFocus News • 7:53am
Roth Capital Adjusts Price Target for Entrada Therapeutics (TRDA) | TRDA Stock News
GuruFocus News • 8:15pm
May 08, 2025
Entrada Therapeutics (TRDA) Reports Strong Q1 Revenue and Advances Duchenne Programs | TRDA Stock News
GuruFocus News • 7:22am
Entrada Therapeutics Inc (TRDA) Q1 2025 Earnings: EPS of -$0.42 Beats Estimates, Revenue Surges to $20.6 Million
GuruFocus News • 6:39am
Entrada Therapeutics Reports First Quarter 2025 Financial Results
Marketwired • 6:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news